Pipradrol and Pipradrol Derivatives

Novel Psychoactive Substances: Classification, Pharmacology and Toxicology

Volumn , Issue , 2013, Pages 233-259

  White, Michael W ^b   Archer, John R H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

2 (diphenylmethyl)pyrrolidine; 2 DPMP; Acute toxicology; D2PM; Death; Derivatives; Desoxypipradrol; Diphenylprolinol; Fatality; Pipradrol; Synthesis

Indexed keywords

EID: 84903804525     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-415816-0.00010-9     Document Type: Chapter

References (130)

1. Werner HW, Tilford CH, inventors; Wm. S. Merrell Co., assignee. Alpha,alpha diaryl piperidino methanols. US Patent 2624739; 1953.
2. Sury E, Hoffmann K Über alkylenimin-derivate. Piperidin-Derivate mit zentralerregender Wirkung I [About alkyleneimine derivatives. Piperidine derivatives with a central stimulant effect I]. Helv Chim Acta 1954, 37:2133-2145. [German].
3. Tripod J, Sury E, Hoffmann K Zentralerregende wirkung eines neuen piperidinderivates [Central stimulant effect of a new piperidine derivative]. Experientia 1954, 10(6):261-262. [German].
4. Bellucci G Il 2-difenilmetil-piperidin-idrocloruro e l'estere metilico dell'acido α-fenilα-piperidil-(2)-cloroacetico, farmaci dotati di azione risvegliante [2-Diphenylmethyl-piperidine hydrochloride and the methyl ester of α-phenylα-(2-piperidyl)-chloroacetic acid: two drugs possessing an awakening action]. Minerva Anestesiol 1955, 21(6):125-128. [Italian].
5. Heer J, Sury E, Hoffmann K Über alkylenimin-derivate. Piperidin-derivate mit zentralerregender Wirkung II [Piperidine derivatives with central stimulant effects]. Helv Chim Acta 1955, 38:134-140. [German].
6. Brown BB, Braun DL, Feldman RG The pharmacologic activity of α-(4-piperidyl)-benzhydrol hydrochloride (Azacyclonol hydrochloride); an ataractive agent. J Pharmacol Exp Ther 1956, 118(2):153-161.
7. McCarty FJ, Tilford CH, Van Campen MG Central stimulants. α,α-Disubstituted 2-piperidinemethanols and 1,1-disubstituted heptahydroöxazolo[3,4-a]pyridines. J Am Chem Soc 1957, 79:472-480.
8. Hoffmann K, Heer J, Sury E, Urech E, inventors; CIBA Pharmaceutical Products, Inc., assignee. 2-Diphenyl-methyl-piperidine. US Patent 2820038; 1958.
9. Hoffmann K, Heer J, Sury E, Urech E, inventors; CIBA Pharmaceutical Products, Inc., assignee. 2-Diphenylmethyl-piperidine compounds. US Patent 2826583; 1958.
10. Hoffmann K, Heer J, Sury E, Urech E, inventors; CIBA Pharmaceutical Products, Inc., assignee. Piperidines and their manufacture. US Patent 2849453; 1958.
11. Belleau B The synthesis of (±),(+) and (-) α-(3-thiamorpholinyl)-benzhydrol, a new selective stimulant of the central nervous system. J Med Pharm Chem 1960, 2(5):553-562.
12. Hoffmann K, Heer J, Sury E, Urech E, inventors; CIBA Pharmaceutical Products, Inc., assignee. Substituted 2-diphenylmethyl-piperidine compounds. US Patent 2957879; 1960.
13. Nodine JH, Bodi T, Slap J, Levy HA, Siegler PE Preliminary trial of a new stimulant SCH 5472 in ambulatory patients with depression, exhaustion, or hypersomnia syndromes. Antibiotic Med Clin Ther 1960, 7:771-776.
14. Winthrop SO, Humber LG Central stimulants. Cyclized diphenylisopropylamines. J Org Chem 1961, 26:2834-2836.
15. Hoffmann K, Sury E, inventors; CIBA Corporation, assignee. 1-Ethyl-2-diphenylmethyl-piperidines. US Patent 3048594; 1962.
16. Roussel-UCLAF, inventor; Nouveau médicament actif sur le systéme nerveux central et doué notamment d'effet psychotonique [New drug active in the central nervous system with particular psychotonic effect]. French Patent [Fr. M 3638]; 1964. [French].
17. Likhosherstov AM, Raevskii KS, Lebedeva AS, Kritsyn AM, Skoldinov AP Azacycloalkanes III. Tertiary α-azacycloalkyl carbinols. Synthesis and pharmacological activity. Pharm Chem J 1967, 1:27-31.
18. Walter LA, Springer CK, Kenney J, Galen SK, Sperber N Derivatives of 3-piperidinol as central stimulants. J Med Chem 1968, 11(4):792-796.
19. Enyedy IJ, Sakamuri S, Zaman WA, Johnson KM, Wang S Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors. Bioorg Med Chem Lett 2003, 13:513-517.
20. Corkery JM, Elliot S, Forbes Forsyth VA, Schifano F, Corazza O, Ghodse AH. First deaths involving 2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-diphenylmethylpiperidine); 2012. In preparation.
21. European monitoring centre for drugs and drug addiction. EDND - European information system and database on new drugs; 2012. [Access restricted to registered users].
22. ACMD Consideration of the Novel Psychoactive Substances ('Legal Highs') 2011, Advisory Council on the Misuse of Drugs, London, Available: [accessed 18.07.12].
23. 3H]dopamine by synaptic vesicles from rat whole brain, striatum and hypothalamus. J Pharmacol Exp Ther 1979, 210(3):422-428.
24. Hoffman K, Sury E, inventors; CIBA Pharmaceutical Products, Inc., assignee. 2(1'-Phenyl-lower alkyl) piperidines and their intermediates. US Patent 2830057; 1958.
25. Jacob RM, Joseph NM, inventors; Rhone-Poulenc, assignee. New esters. US Patent 2928835; 1960.
26. Schmidt D, Hüller H, Amon I, Peters R Zur pharmakologie einer serie von diphenylaminopropanderivaten [A series of diphenylaminopropane derivatives for pharmacology]. Pharmazie 1973, 28(10):677-680. [German].
27. Shafi'ee A, Hite G The absolute configurations of the pheniramines, methyl phenidates, and pipradrols. J Med Chem 1969, 12:266-270.
28. Sperber N, Papa D, inventors; Schering Corporation, assignee. Substituted alkyl piperidines. US Patent 2739969; 1956.
29. Forster W, Henderson AL A clinical study of 'Frenquel' (alpha (4-piperidyl) benzhydrol hydrochloride) in chronic schizophrenia. Can Med Assoc J 1957, 76:97-101.
30. Sperber N, Villani FJ, Papa D, inventors; Schering Corporation, assignee. Substituted piperidines. US Patent 2739968; 1956.
31. Schumann EL, Van Campen, Jr MG, Pogge RC, inventors; Wm. S. Merrell Co., assignee. Tranquilizing composition comprising alpha phenyl, alpha-(4-piperidyl)-benzyl alcohol and method of using same. US Patent 2804422; 1957.
32. ACMD Consideration of desoxypipradrol (2-DPMP) and related pipradrol compounds 2011, Advisory Council on the Misuse of Drugs, London, Available: [accessed 18.07.12].
33. Fabing HD, Hawkins JR, Moulton JAL Clinical studies on α-(2-piperidyl)benzhydrol hydrochloride, a new antidepressant drug. Am J Psychiatry 1955, 111(11):832-836.
34. Tilford CH, Shelton RS, Van Campen MG Histamine antagonists. Basically substituted pyridine derivatives. J Am Chem Soc 1948, 70:4001-4009.
35. Murugan R, Goe GL, Scriven EFV, inventors; Reilly Industries, Inc., assignee. Processes for producing α-pyridyl carbinols. US Patent 5541331; 1996.
36. Portoghese PS, Pazdernik TL, Kuhn WL, Hite G, Shafi'ee A Stereochemical studies on medicinal agents. V. Synthesis, configuration, and pharmacological activity of pipradrol enantiomers. J Med Chem 1968, 11(1):12-15.
37. Rao AVR, Gurjar MK, Sharma PA, Kaiwar V Entantioselective reductions of ketones with oxaborolidines derived from (R) and (S)α,α-diphenyl-2-piperidine methanol. Tetrahedron Lett 1990, 31(16):2341-2344.
38. Krumkalns EV, inventor; Eli Lilly and Company, assignee. Method of regulating the growth of aquatic weeds with pyridine derivatives. US Patent 4043790; 1977.
39. Berger L, Lee J, inventors; Hoffman-La Roche Inc. and Nutley, assignee. 1-Alkyl-3-benzohydryl piperidines. US Patent 2599364; 1952.
40. Jackson PF, Slusher BS, inventors; Guilford Pharmaceuticals Inc., assignee. Pharmaceutical compositions and methods for treating compulsive disorders using pyrrolidine derivatives. US Patent 5925666; 1999.
41. Synthesis of diphenyl-2-pyrrolidinyl-methanol and diphenyl-2-pyrrolidinyl-methane [Review article]. Rhodium archive hosted by Erowid. Available from: <>; August 2004 [accessed 08.11.11]. http://www.erowid.org/archive/rhodium/chemistry/pyrrolidinyl.html.
42. Enders D, Pieter R, Renger B, Seebach D Nucleophilic α-sec-aminoalkylation: 2-(diphenylhydroxymethyl)pyrrolidine. Org Syntheses Coll 1988, 6:542. Available: [accessed 18.07.12].
43. Corey EJ, Shibata T, Lee TW Asymmetric Diels-Alder reactions catalysed by a triflic acid activated chiral oxazaborolidine. J Am Chem Soc 2002, 124(15):3808-3809.
44. Carlone A. Enantioselective aminocatalysis: new reactions and new directions. [PhD Thesis]. Bologna: Università di Bologna; 2008. p. 5. Available: <> [accessed 18.07.12]. http://www.amsdottorato.cib.unibo.it/1040/1/Tesi_Carlone_Armando.pdf.
45. Kanth JVB, Periasamy M Convenient method for the synthesis of chiral α,α-diphenyl-2-pyrrolidinemethanol. Tetrahedron 1993, 49(23):5127-5132.
46. Bailey DJ, O'Hagan D, Tavasli M A short synthesis of (S)-2-(diphenylmethyl)pyrrolidine, a chiral solvating agent for NMR analysis. Tetrahedron Asymmetry 1997, 8(1):149-153.
47. Wood DM, Dargan PI Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP). Clin Toxicol (Phila.) 2012, 50(8):727-732.
48. Drugs info: 2-DPMP/desoxypipradrol [Internet forum]. Drugs-Forum. Available: <>; 2007 [accessed 09.07.12]. http://www.drugs-forum.com/forum/showthread.php?t=30973.
49. Desoxypipradrol research - preliminary conclusions [Internet forum]. Bluelight. Available: <>; 2007 [accessed 10.07.12]. http://www.bluelight.ru/vb/threads/305531-Desoxypipradrol-research-preliminary-conclusions.
50. Begg WGA, Reid AA 'Meratran'; a new stimulant drug. BMJ 1956 April, 1(4973):946-949.
51. Experiences - Diphenyl-2-Pyrrolidinyl-Methanol (dip-henylprolinol) trip reports [Internet forum]. Drugs-Forum. Available: >; 2007 [accessed 12.07.12]. http://www.drugs-forum.com/forum/showthread.php?t=41534.
52. Vree TB, Van Rossum JM Suppression of renal excretion of fencamfamine in man. Eur J Pharmacol 1969, 7(2):227-230.
53. Murray DB, Potts S, Haxton C, Jackson G, Sandilands EA, Ramsey J, et al. 'Ivory wave' toxicity in recreational drug users; integration of clinical and poisons information services to manage legal high poisoning. Clin Toxicol (Phila.) 2012, 50(2):108-113.
54. Herbert JX, Daly F, Tracey JA. Whacked! BMJ Lett. 341. Available: <>; 2010 [accessed 18.07.12]. http://www.bmj.com/rapid-response/2011/11/02/whacked.
55. Wood DM, Puchnarewicz M, Johnston A, Dargan PI A case series of individuals with analytically confirmed acute diphenyl-2-pyrrolidinemethanol (D2PM) toxicity. Eur J Clin Pharmacol 2012 April, 68(4):349-353. [Epub 2011 October 29].
56. WHO Food Additives Series: 56. Safety evaluation of certain food additives. Prepared by the sixty-fifth meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA). Genève: World Health Organization. p. 358-9. Available: <>; 2006 [accessed 18.07.12]. http://www.whqlibdoc.who.int/publications/2006/9241660562_part2_g_eng.pdf.
57. Provigil (modafinil) Tablets. United States: Cephalon, Inc.; Revised October 2010. [Medication Guide]. Available: <> [accessed 12.08.12]. http://www.provigil.com/media/PDFs/prescribing_info.pdf.
58. Brandenberger H Part 3.9 Antihistamines. Analytical toxicology: for clinical, forensic, and pharmaceutical chemists 1997, 546. Walter de Gruyter, Berlin, Available: [accessed 12.08.12]. H. Brandenberger, R.A.A. Maes (Eds.).
59. Kariya S, Isozaki S, Narimatsu S, Suzuki T Oxidative metabolism of cinnarizine in rat liver microsomes. Biochem Pharmacol 1992, 44(7):1471-1474.
60. Wu WN, Hills JF, Chang SY In vivo biotransformation of fenoctimine in rat, dog and man. Xenobiotica 1994, 24(11):1133-1148.
61. Jacobsen E The comparative pharmacology of some psychotropic drugs. Bull World Health Organ 1959, 21:411-493. Available: [accessed 25.08.12].
62. Karczmar AG, Howard JH Anorexigenic action of methylphenidate (Ritalin) and pipradrol (Meratran). Proc Soc Exp Biol Med 1959, 102:163-167.
63. Gelvin EP, McGavack TH, Kenigsberg S Alpha-(2-piperidyl) benzhydrol hydrochloride (pipradrol) as an adjunct in the dietary management of obesity. NY State J Med 1955, 55(16):2336-2338.
64. Brown BB, Werner HW Pharmacologic studies on a new central stimulant, α-(2-piperidyl)benzhydrol hydrochloride (MRD-108). J Pharmacol Exp Ther 1954, 110(2):180-187.
65. Pogge RC Meratran. BMJ 1956, 2(4988):361.
66. Council on Drugs New drugs and developments in therapeutics. JAMA 1962 October, 182(4):346-347. Available: jama.ama-assn.org.
67. Shader RI, Harmatz JS, Kochansky GE, Cole JO Psychopharmacologic investigations in healthy elderly volunteers: effects of pipradrol-vitamin (Alertonic) elixir and placebo in relation to research design. J Am Geriatr Soc 1975, 23(6):277-279.
68. Robbins TW, Watson BA, Gaskin M, Ennis C Contrasting interactions of pipradrol, d-amphetamine, cocaine, cocaine analogues, apomorphine and other drugs with conditioned reinforcement. Psychopharmacology 1983, 80:113-119.
69. White NM, Hiroi N Pipradrol conditioned place preference is blocked by SCH23390. Pharmacol Biochem Behav 1992, 43:377-380.
70. Ross SB, Kelder D Inhibition of 3H-dopamine accumulation in reserpinized and normal rat striatum. Acta Pharmacol Toxicol (Copenh.) 1979, 44:329-335.
71. Information on Prep. No. 14'469 (desoxypipradrol), a new synthetic stimulant with central point of application. Novartis; 1955. [Unpublished report].
72. Maxwell RA, Chaplin E, Batmanglidj Eckhardt S, Soares JR, Hite G Conformational similarities between molecular models of phenethylamine and of potent inhibitors of the uptake of tritiated norepinephrine by adrenergic nerves in rabbit aorta. J Pharmacol Exp Ther 1970, 173(1):158-165.
73. Ferris RM, Tang FLM, Maxwell RA A comparison of the capacities of isomers of amphetamine, deoxypipradrol and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta. J Pharmacol Exp Ther 1972, 181(3):407-416.
74. Davidson C, Ramsey J Desoxypipradrol is more potent than cocaine on evoked dopamine efflux in the nucleus accumbens. J Psychopharmacol 2012, 26(7):1036-1041.
75. Schmitt KC, Zhen J, Kharkar P, Mishra M, Chen N, Dutta AK, et al. Interaction of cocaine-, benztropine-, and GBR12909-like compounds with wild-type and mutant human dopamine transporters: molecular features that differentially determine antagonist-binding properties. J Neurochem 2008, 107:928-940.
76. Jackson PF, inventor; Guilford Pharmaceuticals Inc., assignee. Pyrrolidine derivatives. US Patent 5650521; 1997.
77. Dickerson TJ, Janda KD Recent advances for the treatment of cocaine abuse: central nervous system immunopharmacotherapy. AAPS J 2005, 7(3):579-586. Available: [accessed 06.05.13].
78. Pindell MH, Doran KM, Frenzel KC, Tisch DE Pharmacological studies on 3-(α,α-diphenylα-hydroxymethyl)thiomorpholine HCl, a CNS stimulant. Fed Roc Soc 1959, 78:433.
79. Fabing HD New blocking agent against the development of LSD-25 psychosis. Science 1955, 121:208-210.
80. Wood DM, Hunter L, Measham F, Dargan PI Limited use of novel psychoactive substances in South London nightclubs. QJM 2012, 105(10):959-964.
81. Nordegren T The A-Z encyclopedia of alcohol and drug abuse 2002, Brown Walker Press, Boca Raton, FL, Available:
82. Shulgin AT Drugs of abuse in the future. Clin Toxicol 1975, 8(4):405-456. Available: [accessed 18.07.12].
83. Cooper DA. Future synthetic drugs of abuse. In: Proceedings of the International Symposium on the forensic aspects of controlled substances. Washington, DC: Laboratory Division, FBI, US Government Printing Office. p. 79-103. Available: <>; 1990 [accessed 03.02.12]. http://www.erowid.org/archive/rhodium/chemistry/future_drugs.html.
84. Desoxypipradrol information request [Internet forum]. Bluelight; Postings from February 2007 to June 2009. Available: <> [accessed 03.02.12]. http://www.bluelight.ru/vb/threads/292451-desoxypipradol-information-request.
85. EMCDDA-Europol 2010 Annual Report on the implementation of Council Decision 2005/387/JHA. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. Available: <>; 2011 [accessed 12.07.12]. http://www.emcdda.europa.eu/attachements.cfm/att_132857_EN_EMCDDA-Europol%20Annual%20Report%202010A.pdf.
86. Corkery JM, Elliott S, Schifano F, Corazza O, Ghodse AH 2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol): a preliminary review. Prog Neuropsychopharmacol Biol Psychiatry 2012, June. [Epub ahead of print].
87. Kim HS, Aftab A, Shah M, Nayar J Physical and psychological effects of the new legal high 'Ivory Wave': a case report. BJMP 2010, 3(4):a343.
88. Durham M Ivory Wave: the next mephedrone?. Emerg Med J 2011, 28(12):1059-1060.
89. Kelleher C, Christie R, Lalor K, Fox J, Bowden M, O'Donnell C An overview of new psychoactive substances and the outlets supplying them 2011, National Advisory Committee on Drugs, Dublin, Available: [accessed 18.07.12].
90. Kavanagh PV, Sharma J, McNamara S, et al. Head shop 'legal highs' active constituents identification chart (June/July 2010, '511' - '714') 2010, Department of Pharmacology and Therapeutics, School of Medicine, Trinity Centre for Health Sciences, St James's Hospital, Dublin, Available: [accessed 18.07.12].
91. Home Office. Imports of Desoxypipradrol (2-DPMP, 2-Benzhydrylpiperidine, 2-Diphenylmethylpiperidine) [Home Office notice]. London: Home Office. Available: <>; 4 November 2010 [accessed 15.07.12]. http://www.homeoffice.gov.uk/publications/alcohol-drugs/drugs/drug-licences/desoxypipradrol/.
92. Dangerous Drugs: The Misuse of Drugs Act 1971 (Amendment) Order 2012 [Statutory Instrument]. 30 May 2012[SI 1390].
93. Intelligence alert - Recent, unusual drug submissions in New Zealand. In: Microgram Bulletin. Washington, DC: Drug Enforcement Administration, Office of Forensic Sciences. Available: <>; 2007 [accessed 18.07.12]. http://www.justice.gov/dea/programs/forensicsci/microgram/mg1207/mg1207.html.
94. Gower P. Herald investigation: party pill pushers beat the ban [Media report]. Available: <>; 2007 November 3 [accessed 30.08.12]. http://www.nzherald.co.nz/nz/news/article.cfm?c_id=1&objectid=10473827.
95. ACMD Further advice on diphenylprolinol (D2PM) and diphenylmethylpyrrolidine 10 November 2011, Advisory Council on the Misuse of Drugs, London, Available: [accessed 16.07.12].
96. Wood DM, Puchnarewicz M, Holt DW, Ramsey J, Dargan PI Detection of the precursor benzophenone in individuals who have used legal highs containing diphenyl-2-pyrrolidinemethanol (D2PM). Basic Clin Pharmacol Toxicol 2011, 109(Suppl.1):86.
97. Home Office. Import ban on diphenylprolinol and diphenylmethylpyrrolidine [Home Office Notice]. London: Home Office; 15 November 2011 Available: <> [accessed 16.07.12]. http://www.homeoffice.gov.uk/publications/alcohol-drugs/drugs/import-ban-d2pm.
98. Mysterious stimulant in Slim Xtreme dietary supplement [Internet forum]. Bluelight Available: <>; 2009 [accessed 07.02.12]. http://www.bluelight.ru/vb/threads/462408-Mysterious-stimulant-in-Slim-Xtreme-dietary-supplement.
99. Effects: Difference: 2-(diphenylmethyl)pyrrolidine vs diphenyl-2-pyrrolidinyl-methanol (D2PM) [Internet forum]. Drugs-Forum Available: <>; 2010 [accessed 12.07.12]. http://www.drugs-forum.com/forum/showthread.php?t=143109.
100. Experiences: 2-Diphenylmethylpyrrolidine aka 2-Benzylhydrylpyrrolidin [Internet forum]. Drugs-Forum Available: <>. http://www.drugs-forum.com/forum/showthread.php?t=144908.
101. Toxic designer stim update: confirmed. [Web newspaper]. Steroid Times. Available: <>; 2009 [accessed 07.02.12]. http://www.steroidtimes.com/toxic-designer-stim-update-confirmed/2009.
102. Lidder S, Dargan PI, Sexton M, et al. Cardiovascular toxicity associated with recreational use of diphenylprolinol (diphenyl-2-pyrrolidinemethanol [D2PM]). J Med Toxicol 2008, 4(3):167-169.
103. Wood DM, Button J, Lidder S, Ovaska H, Ramsey J, Holt DW, et al. Detection of the novel recreational drug diphenyl-2-pyrrolinemethanol (D2PM) sold 'legally' in combination with glaucine. Clin Toxicol 2008, 46(5):393.
104. Sistema nazionale di allerta precoce per le droghe [National Early Warning System for Drugs]. 2-(Diphenylmethyl)pyrrolidine (desoxy-D2PM). Rome: Dipartimento Politiche Antidroga. [Italian]. Available: <>; 2010 [accessed 12.07.12]. http://www.droganews.it/pubdownload.php?id=2472.
105. Nayar S. Green Powder called A3A Methano.: Cambridgeshire Constabulary. Available: <>; 2010 [accessed 12.07.12]. http://ewsd.wiv-isp.be/Other%20information%20on%20new%20psychoactive%20substances/Desoxy-D2PM/Report_UK_Dec%202010_Green%20Powder%20called%20A3A%20Methano.pdf.
106. Di Chirara G, Gessa GL Pharmacology and neurochemistry of apomorphine. Adv Pharmacol Chemother 1978, 15:87-160.
107. Small SF, Quock RM, Malone MH Pipradrol-induced hyperthermia in the rabbit. Pharmacol Res Commun 1984, 16(9):923-931.
108. Pipradrol hydrochloride toxicity data [Datasheet]. LookChem Available: <>; 2012 [accessed 13.01.12]. http://www.lookchem.com/TempWithNoSign.aspx?cas=71-78-3&key=pipradrol+hydrochloride.
109. ChemIDplus Advanced [Database]. United States: National Library of Medicine. Available: <>; 2012 [accessed 13.01.12]. http://chem.sis.nlm.nih.gov/chemidplus.
110. Inchem. Methylphenidate hydrochloride [Poisons Information Monographs]. International Programme on Chemical Safety (Revised August 1997). Available: <>; 1992 [accessed 09.07.12]. http://www.inchem.org/documents/pims/pharm/pim344.htm.
111. Hintze KL, Aboul-Enein HY, Fischer LJ Isomeric specificity of diphenylmethylpiperidine in the production of rat pancreatic islet cell toxicity. Toxicology 1977, 7:133-140.
112. Miller CP, Reape TJ, Fischer LJ Inhibition of insulin production by cyproheptadine in RINm5F rat insulinoma cells. J Biochem Toxicol 1993, 8(3):127-134.
113. Rickels K, Schneider B, Pereira-Organ JA, Perloff MM, Segal A, Vandervort W Pipradrol in mild depression: a controlled study. J Clin Pharmacol 1974, 14:127-133.
114. Convention on Psychotropic Substances. Vienna: International Narcotics Control Board. Available: <>; 1971 [accessed 20.07.12]. http://www.incb.org/incb/convention_1971.html.
115. Martindale: the complete drug reference [online pharmacopoeia]. Medicines Complete. Available: >; 2012 [accessed 10.09.12]. http://www.medicinescomplete.com/mc/martindale/current/login.htm.
116. Alertonic elixir [Information sheet]. South African electronic package inserts.; Published 26/2/75 and updated April 2004. Available: <> [accessed 06.01.12]. http://www.home.intekom.com/pharm/adcock/alerton.html.
117. Coppola M, Mondola R Research chemicals marketed as legal highs: the case of pipradrol derivatives. Toxicol Lett 2012, 212:57-60.
118. Psychonaut. Desoxypipradrol technical paper. London: Psychonaut Web Mapping Research Group. Institute of Psychiatry, King's College London. Available: <>; 2009 [accessed 14.08.12]. http://www.rednetproject.eu/groups/2dpmp.
119. Drassdo A, Schmidt M Effect of 2-diphenylmethylpiperidine hydrochloride on blood circulation, mental capacity and metabolism. Medizinische Monatsschrift fur Pharmazeuten 1956, 10(11):738-743. [German].
120. LoGiCal. Analytical monograph: Desoxypipradrol. LGC Standards; Last revised 23 July 2012. Available: <> [accessed 30.07.12]. http://www.logical-standards.com/uploads/pdfs/english/Desoxypipradol_with%20copyright.pdf.
121. Kaizaki A, Tanaka S, Tsujikawa K, Numazawa S, Yoshida T Recreational drugs, 3,4-methylenedioxymethamphetamine (MDMA), 3,4-methylenedioxyamphetamine (MDA) and diphenylprolinol, inhibit neurite outgrowth in PC12 cells. J Toxicol Sci 2010, 35(3):375-381.
122. Bejerot N. Narkotikafrågan och samhället [Drug issues in the community], 2nd ed. Volume 28 of Aldus aktuellt. Stockholm: Bokförlaget aldus/Bonnier. [Swedish]. Available: <>; 1968 [accessed 18.07.12]. http://www.nilsbejerot.se/samhallet.pdf.
123. King LA Chapter 5: Drug legislation in the UK. Forensic chemistry of substance misuse 2009, Royal Society of Chemistry, Cambridge, p. 31.
124. Department of Health and Social Security The amphetamines and lysergic acid diethylamide (LSD): report by the Advisory Committee on Drug Dependence 1970, HMSO, London.
125. Shorter E The drug efficacy study in 1966-1968. Reflections on twentieth century psychopharmacology 2004, 75-76. CINP, Available: [accessed 18.07.12]. T.A. Ban, D. Healy, E. Shorter (Eds.).
126. Isbell H, Chruáciel TL Dependence liability of 'non-narcotic' drugs 1970, World Health Organization, Geneva, Available: [accessed 18.07.12].
127. Goldberg L Drug abuse in Sweden (I). Bull Narcot 1968, 20(1):1-31.
128. Goldberg L Drug abuse in Sweden (II). Bull Narcot 1968, 20(2):9-36.
129. World Health Organization. Technical Report Series No. 437. WHO Expert Committee on Drug Dependence, Seventeenth Report. Geneva: World Health Organization. Available: <>; 1970 [accessed 18.07.12]. http://www.whqlibdoc.who.int/trs/WHO_TRS_437.pdf.
130. Annual report on the Home Office forensic early warning system (FEWS). Home Office. Available: <>; 2012 [accessed 07.09.12]. http://www.homeoffice.gov.uk/publications/alcohol-drugs/drugs/drug-strategy/fews.